A mutation in the low-complexity domain of splicing factor hnRNPA1 linked to amyotrophic lateral sclerosis disrupts distinct neuronal RNA splicing networks
Genes & Development · 01.01.2024 · 38 (1-2) · 11-30
DOI: 10.1101/gad.351104.123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Development, online erschienen am 05.01.2024. Verfasst von Yeon J Lee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California 94720, USA. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Heterogeneous-Nuclear Ribonucleoprotein Group A-B, Neurodegenerative Diseases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCRR NIH HHS, NIGMS NIH HHS, NIH.
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS) is a debilitating neurodegenerative disease characterized by loss of motor neurons. Human genetic studies have linked mutations in RNA-binding proteins as causative for this disease. The hnRNPA1 protein, a known pre-mRNA splicing factor, is mutated in some ALS patients. Here, two human cell models were generated to investigate how a mutation in the C-terminal low-complexity domain (LCD) of hnRNPA1 can cause splicing changes of thousands of transcripts that collectively are linked to the DNA damage response, cilium organization, and translation. We show that the hnRNPA1 D262V mutant protein binds to new binding sites on differentially spliced transcripts from genes that are linked to ALS. We demonstrate that this ALS-linked hnRNPA1 mutation alters normal RNA-dependent protein–protein interactions. Furthermore, cells expressing this hnRNPA1 mutant exhibit a cell aggregation phenotype, markedly reduced growth rates, changes in stress granule kinetics, and aberrant growth of neuronal processes. This study provides insight into how a single amino acid mutation in a splicing factor can alter RNA splicing networks of genes linked to ALS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California 94720, USA.
- California Institute for Quantitative Biosciences (QB3), University of California, Berkeley, Berkeley, California 94720, USA.
- Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California 94720, USA; don_rio@berkeley.edu.
Förderung
- NCRR NIH HHS
- NIGMS NIH HHS
- NIH
Zitieren
APA
Lee, Y. J., & Rio, D. C. (2024). A mutation in the low-complexity domain of splicing factor hnRNPA1 linked to amyotrophic lateral sclerosis disrupts distinct neuronal RNA splicing networks. Genes & Development, 38(1-2), 11-30. https://doi.org/10.1101/gad.351104.123
Vancouver
Lee YJ, Rio DC. A mutation in the low-complexity domain of splicing factor hnRNPA1 linked to amyotrophic lateral sclerosis disrupts distinct neuronal RNA splicing networks. Genes & Development. 2024;38(1-2):11-30. doi:10.1101/gad.351104.123
BibTeX
@article{Lee2024,
author = {Lee, Yeon J and Rio, Donald C},
title = {A mutation in the low-complexity domain of splicing factor hnRNPA1 linked to amyotrophic lateral sclerosis disrupts distinct neuronal RNA splicing networks},
journal = {Genes & Development},
year = {2024},
volume = {38},
number = {1-2},
pages = {11--30},
doi = {10.1101/gad.351104.123}
}
EUVIMED